A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript

导出原文传递

翻译打印收藏纠错

作者： Grohar, Patrick J. ^[1] ; Glod, John ^[2] ; Peer, Cody J. ^[3] ; Sissung, Tristan M. ; Arnaldez, Fernanda I. ; Long, Lauren ; Figg, William D. ; Whitcomb, Patricia ; Helman, Lee J. ; Widemann, Brigitte C.

作者单位： NCI, Clin Pharmacol Program, Bethesda, MD 20892 USA ^[1] NCI, Ctr Canc Res, Pediat Oncol Branch, Bethesda, MD 20892 USA ^[2] Michigan State Univ, Dept Pediat, Van Andel Res Inst, Helen DeVos Childrens Hosp, E Lansing, MI ^[3]

关键词 Ewing sarcoma Mithramycin EWS-FLI1

发布时间 2018-05-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Cancer Chemotherapy and Pharmacology

2017年80卷3期

645-652页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript

Cancer Chemotherapy and Pharmacology

相似文献

Cancer Chemotherapy and Pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

A phase I/II trial and pharmacokinetic study of mithramycin in children and adults with refractory Ewing sarcoma and EWS-FLI1 fusion transcript

Cancer Chemotherapy and Pharmacology

相似文献

Cancer Chemotherapy and Pharmacology

相关期刊

检索历史清除